thiabendazole has been researched along with Helicobacter Infections in 1 studies
Tresaderm: dermatologic soln containing dexamethasone, thiabendazole & neomycin sulfate
Helicobacter Infections: Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mendz, GL | 1 |
| Hazell, SL | 1 |
| Srinivasan, S | 1 |
1 other study available for thiabendazole and Helicobacter Infections
| Article | Year |
|---|---|
Fumarate reductase: a target for therapeutic intervention against Helicobacter pylori.
Topics: Aconitate Hydratase; Anti-Bacterial Agents; Fumarate Hydratase; Helicobacter Infections; Helicobacte | 1995 |